What framework governs reverse payment settlements under FTC v. Actavis?

What framework governs reverse payment settlements under FTC v. Actavis?

• A. Presumptively legal
• B. Presumptively illegal
• C. Rule of reason analysis
• D. Automatic invalidation if large

Answer: (C)

The framework is the rule of reason analysis. In FTC v. Actavis, the Supreme Court held that reverse payment settlements between brand-name drug manufacturers and generic challengers are not categorically lawful or unlawful. Instead, they are subject to the rule of reason, which requires weighing the settlement’s potential anticompetitive effects against any procompetitive justifications (like settling litigation, avoiding costly trial, or expediting generic entry in a way that could ultimately benefit consumers). The analysis looks at factors such as the size of the payment, the strength of the patent, market conditions, and the settlement’s impact on competition. The Court rejected a per se rule, so large payments aren’t automatically illegal, though they can be highly probative of anticompetitive intent under this framework.

The framework is the rule of reason analysis. In FTC v. Actavis, the Supreme Court held that reverse payment settlements between brand-name drug manufacturers and generic challengers are not categorically lawful or unlawful. Instead, they are subject to the rule of reason, which requires weighing the settlement’s potential anticompetitive effects against any procompetitive justifications (like settling litigation, avoiding costly trial, or expediting generic entry in a way that could ultimately benefit consumers). The analysis looks at factors such as the size of the payment, the strength of the patent, market conditions, and the settlement’s impact on competition. The Court rejected a per se rule, so large payments aren’t automatically illegal, though they can be highly probative of anticompetitive intent under this framework.